For men without hypogonadism, the risks of testosterone therapy side effects may outweigh the benefits. In January 2014, the FDA began investigating studies linking testosterone to a 30% increased risk of heart attack, stroke, and death in the first 90 days of treatment. Other studies indicate that testosterone may significantly increase a man’s risk of blood clots and heart attack — especially for men over 65 and those with heart disease.
UPDATE: Canadian Lawyers file Testosterone Class Action Lawsuits
July 25, 2014 — Attorneys in Canada have filed two class action lawsuits against the manufacturers of AndroGel (testosterone gel) and Delatestryl (testosterone injection). These class actions are seeking recovery on behalf of Canadians who purchased testosterone products. Click here to read more.
- AndroGel class action filed on June 26.
- Delatestryl class action filed on July 22 in the Ontario Superior Court of Justice.
Testosterone replacement therapy (TRT) has been prescribed to millions of middle-aged men who have symptoms of “low testosterone” — low energy, muscle weakness, depressed mood, sexual dysfunction, and more.
Testosterone replacement products include:
- Androgel (AbbVie Inc.) – Topical gel applied to skin
- Androderm (Actavis) – Patch
- Axiron (Lilly USA, LLC) – Underarm liquid/cream
- Bio-T-Gel (Teva Pharmaceuticals) – Topical gel applied to skin
- Delatestryl (Endo Pharmaceuticals) – Injection
- Depo-Testosterone (Unigen Life Sciences) – Injection
- Fortesta (Endo Pharmaceuticlas) – Topical gel applied to skin
- Striant (Auxilium Pharmaceuticals) – Buccal tablet absorbed through gums
- Testim (Auxilum Pharmaceuticals) – Topical gel applied to skin
- Testopel (Auxilium Pharmaceuticals) – Subcutaneous pellet